New iron chelators from thiosemicarbazone group in photodynamic therapy
2019/35/N/NZ7/02780
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ5_007: Leczenie chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych
Voivodeship: śląskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 18 – announced on 2019-09-16
- Amount awarded
- 182 400 PLN
- Project start date
- 2020-07-22
- Project end date
- 2023-07-21
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
A Thiosemicarbazone Derivative as a Booster in Photodynamic Therapy—A Way to Improve the Therapeutic Effect
- Authors:
- Robert Gawecki, Jaroslaw Polanski, Anna Mrozek-Wilczkiewicz
- Academic press:
- International Journal of Molecular Sciences (year: 2022, volume: 23, pages: brak), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms232315370 – link to the publication